Previous 10 | Next 10 |
Mylan N.V. (NASDAQ: MYL ) and Pfizer's (NYSE: PFE ) Upjohn unit will merge in an all-stock reverse Morris Trust transaction. More news on: Mylan N.V., Pfizer Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Negotiators for the U.S. and China are facing off in Shanghai this week in another attempt to piece ...
The WSJ reports that Pfizer (NYSE: PFE ) is in talks with Mylan N.V. (NASDAQ: MYL ) to combine its off-patent drugs business with the latter. More news on: Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Limited, Healthcare stocks news, Merger & acquisition news, Stocks on th...
HERTFORDSHIRE, England and PITTSBURGH and NEW YORK , July 29, 2019 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, ...
Mylan (NASDAQ: MYL ): Q2 Non-GAAP EPS of $1.03 beats by $0.08 ; GAAP EPS of -$0.33. More news on: Mylan N.V., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
HERTFORDSHIRE, England and PITTSBURGH , July 29, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and six months ended June 30, 2019. Second Quarter 2019 Financial Highlights U.S. GAAP diluted loss per ordinary share...
Noteworthy events during the week of July 28 - August 3 for healthcare investors. More news on: Pluristem Therapeutics Inc., Mylan N.V., Intra-Cellular Therapies, Inc., Healthcare stocks news, , Read more ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Pfizer (NYSE: PFE ) is close to a deal to combine its off-patent drugs business with Mylan (NASDAQ: MYL ), The Wall Street Journal reports. More news on: Pfizer Inc., Mylan N.V., Healthcare stocks news, Merger & acquisition news, Top stock market news Read more ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...